0001415889-24-017837.txt : 20240621
0001415889-24-017837.hdr.sgml : 20240621
20240621162016
ACCESSION NUMBER: 0001415889-24-017837
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240620
FILED AS OF DATE: 20240621
DATE AS OF CHANGE: 20240621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COOPER GRAHAM K
CENTRAL INDEX KEY: 0001396943
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38542
FILM NUMBER: 241060688
MAIL ADDRESS:
STREET 1: C/O RECEPTOS, INC.
STREET 2: 10835 ROAD TO THE CURE, SUITE 205
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kezar Life Sciences, Inc.
CENTRAL INDEX KEY: 0001645666
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473366145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-822-5600
MAIL ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4-06212024_040605.xml
X0508
4
2024-06-20
0001645666
Kezar Life Sciences, Inc.
KZR
0001396943
COOPER GRAHAM K
C/O KEZAR LIFE SCIENCES, INC.
4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
0
Stock Option (right to buy)
0.67
2024-06-20
4
A
0
50000
0
A
2034-06-19
Common Stock
50000
50000
D
One-hundred percent (100%) of the shares subject to the option shall vest on 6/20/2025, subject to Reporting Person continuing to provide service through such date.
/s/ Marc Belsky, Attorney-in-Fact
2024-06-21